Mersana Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Mersana Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mersana Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mersana Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.3M | 303k | 7.76 |